Chaparral Labs
back to search

protein

Apolipoprotein B-100

aka Apo B-100

APOB
protein:P04114disease:adad:direction:up

Gene

APOB

Organism

Homo sapiens(9606)

Length

4563 aa

Mass

515,545 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Apolipoprotein B-100 (ApoB-100) is the major protein constituent of low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) particles. It functions as a recognition signal for cellular binding and internalization of LDL particles via the apoB/E receptor (UniProt: P04114).

ApoB-100 is a central player in lipid metabolism and transport. Mutations in APOB are associated with familial hypobetalipoproteinemia and familial hypercholesterolemia (UniProt: P04114), both of which affect serum cholesterol and lipoprotein levels with implications for cardiovascular and neurological health.

In Alzheimer's Disease, ApoB-100 shows increased abundance in post-mortem AD brain tissue relative to age-matched controls (mean log2 fold-change: 0.78; Chaparral AD proteomics). This upregulation was detected via TMT-labeled tandem mass spectrometry across subcellular fractions from human brain homogenates, suggesting a potential role in AD pathophysiology, possibly related to altered lipid metabolism or amyloid-associated processes.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↑ Up in AD

P3

not detected

P2

not detected

S2

+0.778

S3

not detected

Mean log₂FC across detected fractions: +0.7782 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor

Disease associations

  • Hypobetalipoproteinemia, familial, 1FHBL1

    A disorder of lipid metabolism characterized by less than 5th percentile age- and sex-specific levels of low density lipoproteins, and dietary fat malabsorption. Clinical presentation may vary from no symptoms to severe gastrointestinal and neurological dysfunction similar to abetalipoproteinemia.

  • Hypercholesterolemia, familial, 2FHCL2

    A form of hypercholesterolemia, a disorder of lipoprotein metabolism characterized by elevated serum low-density lipoprotein (LDL) cholesterol levels, which result in excess deposition of cholesterol in tissues and leads to xanthelasma, xanthomas, accelerated atherosclerosis and increased risk of premature coronary heart disease. FHCL2 inheritance is autosomal dominant.

Sources

Last updated 5/8/2026, 6:31:12 AM